ARCHIVES

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

In Brief: Schweiler Resigns, President Appoints Former Massachusetts Congresswoman Margaret Heckler

January 21, 1983

Natcher Subcommittee Objects To Budget Reductions, Squeeze From DeVita Details On Programs Being Cut

March 15, 1985

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

White Heads NIH Legislative Policy Office

March 5, 2010

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992